Skip to Main Content

Author Details

Ayman Oweida
Universite de Sherbrooke
2004
39
17
PMIDPaper TitleJournal TitlePublished Year
34264178Reconciling two opposing effects of radiation therapy: stimulation of cancer cell invasion and activation of anti-cancer immunity.Int J Radiat Biol2023
37124531A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease.Front Oncol2023
37112730Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities.Vaccines (Basel)2023
36326893Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.Cancer Immunol Immunother2023
34559306Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma.Cancer Immunol Immunother2022
34793974Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC.Mol Ther2022
33097963Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.Cancer Immunol Immunother2021
33883256Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.J Immunother Cancer2021
33485341Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response.J Transl Med2021
33526513Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.Cancer Res2021
30977524Epidemiology and treatment trends for primary tracheal squamous cell carcinoma.Laryngoscope2020
32139402PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models.Clin Cancer Res2020
32567728The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.Mol Carcinog2020
30403264Effects of ranibizumab and amfenac on the functional abilities and radiosensitivity of uveal melanoma cells.Arq Bras Oftalmol2019
31276586Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma.Neuro Oncol2019
30894369Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.Cancer Res2019
30863843STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.J Natl Cancer Inst2019
30944125Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.Clin Cancer Res2019
30766539Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.Front Immunol2019
31058896Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment.J Vis Exp2019
29774792Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.Thyroid2018
29970482Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.Mol Cancer Ther2018
30098782Nomogram for preoperative prediction of nodal extracapsular extension or positive surgical margins in oropharyngeal squamous cell carcinoma.Oral Oncol2018
30042205Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.Clin Cancer Res2018
29848571Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.Clin Cancer Res2018
30084837Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer.Clin Cancer Res2018
27649287Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors.Mol Carcinog2017
28360821Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma.Cancer Cell Int2017
28374095Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.J Neurooncol2017
29416719Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer.Oncotarget2017
29153603Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy.J Neuroimmunol2017
29123967Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma.Oncoimmunology2017
28764811Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy.J Transl Med2017
27727461A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.Cancer2017
27109097Ablative versus fractionated radiation therapy: a controversial role in cancer invasion and metastasis.Oncogene2016
27941840Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas.Sci Rep2016
27096542Differential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cells.Cancer Biol Ther2016
17659552Iron-oxide labeling of hematogenous macrophages in a model of experimental autoimmune encephalomyelitis and the contribution to signal loss in fast imaging employing steady state acquisition (FIESTA) images.J Magn Reson Imaging2007
15296673Cellular imaging at 1.5 T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide.Mol Imaging2004
  • 1 - 39 of 39

Recommended Authors

National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 1
Emory University
Career Start Year 2011
Number of shared co-authors 0
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year 2011
Number of shared co-authors 0
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Moores Cancer Center, University of California San Diego
Career Start Year 2010
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 0
George Washington University
Career Start Year 2007
Number of shared co-authors 1
Juravinski Cancer Centre
Career Start Year 2006
Number of shared co-authors 0
Cornell University
Career Start Year 2005
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 3
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 0
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 2
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 0
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 0
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 0
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 1
Radboud University, Nijmegen Medical Centre
Career Start Year 1995
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 2
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Weill Cornell Medical College
Career Start Year 1986
Number of shared co-authors 1
Weill Cornell Medical College
Career Start Year 1985
Number of shared co-authors 1
National Institute of Deafness and Other Communication Disorders
Career Start Year 1984
Number of shared co-authors 0

Collaborators

University of Colorado School of Medicine
Co-authored papers 29
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 19
University of Colorado
Co-authored papers 15
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers 11
University of Colorado Anschutz Medical Campus
Co-authored papers 10
Sidney Kimmel Cancer Center at Thomas Jefferson University
Co-authored papers 7
University of Colorado School of Medicine
Co-authored papers 5
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Co-authored papers 4
University of Colorado
Co-authored papers 4
University of Colorado Anschutz Medical Campus
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3
University of Colorado School of Medicine
Co-authored papers 3
University of Colorado Denver
Co-authored papers 3
University of Colorado Anschutz Medical Campus
Co-authored papers 3
Mount Sinai Hospital
Co-authored papers 3
University of Colorado
Co-authored papers 2
Co-authored papers 2
University of Colorado Denver | Anschutz Medical Campus
Co-authored papers 2
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 2
University of Colorado Denver
Co-authored papers 2
Huntsman Cancer Institute, The University of Utah
Co-authored papers 2
Earle A. Chiles Research Institute, Providence Cancer Institute
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
University of California
Co-authored papers 1
Dartmouth College Geisel School of Medicine, Princeton University, University of Colorado Anschutz Medical Campus, University of Pennsylvania Perelman School of Medicine
Co-authored papers 1
Cardiovascular Institute, University of Colorado Denver Anschutz Medical Campus
Co-authored papers 1
University of Colorado School of Medicine
Co-authored papers 1